Adalimumab (40mg)
Plamumab 40mg Injection (0.8ml Each) is given by a healthcare professional and should not be self-administered. You should use it regularly and at the same time each day to get the maximum benefit from it. Continue using it as recommended by your doctor and complete the dose even if you feel better.Some of the common side effects of this medicine include headache, sinus inflammation, rash upper respiratory tract infection, and injection site reactions such as pain, redness, and swelling. Talk to your doctor if any of these side effects do not go away with time or get worse. Your doctor may help with ways to reduce or prevent these symptoms.To make sure the medicine is safe for you, before taking it, let your doctor know if you have any problems with your heart, kidneys, or liver. You should also tell your doctor about all the other medicines you are taking. It is important for pregnant and breastfeeding women to ask the advice of their doctors before taking this medicine.There is a Patient Support Program/Patient Assistance Program available in India for this medicine, being managed by DawaiWala. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Plamumab
1 Injection
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Plamumab 40mg Injection (0.8ml Each) blocks the action of certain chemical messengers that are responsible for inflammation, swelling and redness associated with certain joint diseases.
Related Warnings
Consuming alcohol with Plamumab 40mg Injection (0.8ml Each) does not cause any harmful side effects.
Plamumab 40mg Injection (0.8ml Each) is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Plamumab 40mg Injection (0.8ml Each) is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Plamumab 40mg Injection (0.8ml Each) may cause side effects which could affect your ability to drive.
Plamumab 40mg Injection (0.8ml Each) may cause room spinning sensation and vision disturbances. This may affect your driving ability.
There is limited information available on the use of Plamumab 40mg Injection (0.8ml Each) in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Plamumab 40mg Injection (0.8ml Each) in patients with liver disease. Please consult your doctor.
Plamumab 40mg Injection (0.8ml Each) belongs to a class of drugs name TNF blockers. It reduces joint damage by reducing swelling and improves joint function.
You may notice a lessening of joint swelling, pain, and stiffness, often within the first 8 weeks of starting the treatment.
Plamumab 40mg Injection (0.8ml Each) is a TNF blocker medicine that can lower the ability of your immune system to fight infections. Inform your doctor if you have been suffering from any infections before taking this medicine.
Plamumab 40mg Injection (0.8ml Each) is a biological disease-modifying antirheumatic drug (bDMARD) and may be used with other medicines like methotrexate (DMARDs); prednisolone (steroid); naproxen or ibuprofen (anti-inflammatory medicines) and paracetamol (pain killers). However, it cannot be used with other bDMARDs. Your doctor will be able to give you more information on this.
Yes, treatment with this medicine should be stopped before surgery. It can start again after the operation at a time decided by your surgeon and rheumatologist (often once the wound has healed and there is no infection).
